IP Library Assignment 048504/0666
Patent Assignment
Reel/Frame 048504/0666

Change of Name

Recorded: 2019-03-05 Pages: 4
Assignor
ALDEXA THERAPEUTICS, INC.
Executed: 2014-03-17
Assignee
ALDEYRA THERAPEUTICS, INC.
131 HARTWELL AVENUE, SUITE 320, LEXINGTON, MASSACHUSETTS, 02421
Covered Property (1)
Compositions and Methods of Treating Retinal Disease
Application: 16/241,851 →
Publication: US 2019/0210971
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 5, 2019
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 048504/0074 →
Change of Address Mar 5, 2019
From: NEURON SYSTEMS, INC.
To: NEURON SYSTEMS, INC.
Reel/Frame 048504/0365 →
Change of Name Mar 5, 2019
From: NEURON SYSTEMS, INC.
To: ALDEXA THERAPEUTICS, INC.
Reel/Frame 048504/0479 →
Assignment of Assignor's Interest Feb 10, 2021
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 055208/0421 →